rxstat › Shortages › Ticagrelor

Ticagrelor shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ticagrelor is in a widespread shortage in Canada. 2 of 4 reported products are affected. The latest manufacturer estimate for full recovery is Jul 31, 2026.
Products affected
2 / 4
In shortage since
Apr 20, 2026
Est. full return
Jul 31, 2026
Reports on file
21
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-TICAGRELOR
90MG · TABLET · APOTEX INC
DIN 02482630 · since May 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · since Apr 20, 2026, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Mar 9, 2026 · Disruption of the manufacture of the drug.
Avoided
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-TICAGRELOR
90MG · TABLET · APOTEX INC
DIN 02482630 · ended Jan 9, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TICAGRELOR
60MG · TABLET · APOTEX INC
DIN 02482622 · ended Jul 18, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 21 reports. All reports are on file with Health Canada.

What's happening

Ticagrelor is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC, TARO PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ticagrelor is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).

Recent changes

Common questions

When will Ticagrelor be back in stock in Canada?

The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ticagrelor in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedPartial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageRivaroxaban5 of 18 reported products affected · est. return Nov 30, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.